Peptide hormones, metformin and new-wave practices and research therapies

3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Prescription medicines are progressively being abused to augment appearance. Information gleaned from the sporting arena is being extrapolated to the domestic market merely because of the increase in obesity in the population. The list of the types of drug use and their metabolic effects is diverse and includes drugs that are believed to increase the basal metabolic rate (clenbuterol, ephedrine, recombinant human growth hormone, insulin-like growth factor-1 Long arm 3, thyroxine) prevent fat absorption (orlistat) or affect neurochemical modulators (sibutramine). Such drugs if used indiscriminately even with medical supervision, can cause serious long-term sequelae and call their use into question?.

Cite

CITATION STYLE

APA

Graham, M. R., Baker, J. S., & Davies, B. (2016). Peptide hormones, metformin and new-wave practices and research therapies. In Chemically Modified Bodies: The Use of Diverse Substances for Appearance Enhancement (pp. 201–229). Palgrave Macmillan. https://doi.org/10.1057/978-1-137-53535-1_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free